Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.
Adolescent
Anti-Inflammatory Agents
/ administration & dosage
Child
Child, Preschool
Chronic Disease
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Israel
Male
Nephrotic Syndrome
/ diagnosis
Pilot Projects
Prednisone
/ administration & dosage
Prospective Studies
Recurrence
Risk Assessment
Severity of Illness Index
Time Factors
Treatment Outcome
Low dose
Prednisone
Steroid treatment
Steroid-sensitive nephrotic syndrome
Journal
European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
21
03
2019
accepted:
14
10
2019
revised:
10
10
2019
pubmed:
16
11
2019
medline:
20
11
2020
entrez:
16
11
2019
Statut:
ppublish
Résumé
Relapses of steroid-sensitive nephrotic syndrome are traditionally treated with prednisone 2 mg/kg/day or 60 mg/m
Identifiants
pubmed: 31728673
doi: 10.1007/s00431-019-03506-5
pii: 10.1007/s00431-019-03506-5
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Prednisone
VB0R961HZT
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
279-283Références
Buchman AL (2001) Side effects of corticosteroid therapy. J Clin Gastroenterol 33:289–294
doi: 10.1097/00004836-200110000-00006
Deschênes G, Vivarelli M, Peruzzi L, ESPN Working Group on Idiopathic Nephrotic Syndrome (2017) Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries. Eur J Pediatr 176:647–654. https://doi.org/10.1007/s00431-017-2891-2892
doi: 10.1007/s00431-017-2891-2892
pubmed: 28303389
Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639
doi: 10.1016/S0140-6736(03)14184-0
Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747–757. https://doi.org/10.1542/peds.2008-1559
doi: 10.1542/peds.2008-1559
pubmed: 19651590
Lombel RM, Gipson DS, Hodson EM, Kidney Disease: Improving Global Outcomes (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415–426. https://doi.org/10.1007/s00467-012-2310-x
doi: 10.1007/s00467-012-2310-x
pubmed: 23052651
Mehls O, Hoyer PF (2011) Dosing of glucocorticosteroids in nephrotic syndrome. Pediatr Nephrol 26:2095–2098. https://doi.org/10.1007/s00467-011-1993-8
doi: 10.1007/s00467-011-1993-8
pubmed: 21904778
Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F (2010) Behavioural abnormalities in children with nephrotic syndrome. Nephrol Dial Transplant 25:2537–2541. https://doi.org/10.1093/ndt/gfq097
doi: 10.1093/ndt/gfq097
pubmed: 20200003
Pasini A, Aceto G, Ammenti A, NefroKid Study Group et al (2015) Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol 30:91–101. https://doi.org/10.1007/s00467-014-2903-7
doi: 10.1007/s00467-014-2903-7
pubmed: 25127916
Raja K, Parikh A, Webb H, Hothi D (2017) Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children. Pediatr Nephrol 32:99–105
doi: 10.1007/s00467-016-3458-6
Raman V, Krishnamurthy S, Harichandrakumar KT (2016) Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial. Pediatr Nephrol 31:595–604. https://doi.org/10.1007/s00467-015-3285-1
doi: 10.1007/s00467-015-3285-1
pubmed: 26759000
Samuel S, Morgan CJ, Bitzan M, Mammen C, Dart AB, Manns BJ, Alexander RT, Erickson RL, Grisaru S, Wade AW, Blydt-Hansen T, Feber J, Arora S, Licht C, Zappitelli M (2013) Substantial practice variation exists in the management of childhood nephrotic syndrome. Pediatr Nephrol 28:2289–2298. https://doi.org/10.1007/s00467-013-2546-0
doi: 10.1007/s00467-013-2546-0
pubmed: 23917450
Tarshis P, Tobin JN, Bernstein J, Edelman CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the international study of kidney disease in children. J Am Soc Nephrol 8:769–776